Expanded Access for CC-10004

Description

This is an expanded access program (EAP) for eligible participants designed to provide access to CC-10004.

Study Start Date

Not specified

Estimated Completion Date

Not specified

Interventions

  • Drug: CC-10004

Study ID

Celgene -- CC-10004

Status

Available

Trial ID

NCT03740516

Study Type

Expanded Access

Trial Phase

Not Listed

Enrollment Quota

Not Listed

Sponsor

Celgene

Inclusion Criteria

Exclusion Criteria

Gender

All

Ages

N/A

Accepts Healthy Volunteers

Not Listed

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Celgene - Summit, New Jersey 67.8 miles None None None

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.